Insider · CIK 0001676780
Nicholas Michael Westfall
officer
Files at CHE (CHEMED CORP). First filing Aug 5, 2025, latest Aug 5, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $4.2M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CHE: CHEMED CORP
CHEOct 9, 2026 · close 499.82
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 68Notable | CHEMED CORP | $4.2M 10,012 shares | -100% | +3% from low-32% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 4, 2025 | CHE CHEMED CORP | SOpen-market sale Capital Stock | -10,012 | $421.91 | $4.2M | 0 | Aug 5, 2025 |
| May 9, 2025 | CHE CHEMED CORP | MOption exercise Capital Stock | +16,132 | $445.35 | $7.2M | 23,056 | May 12, 2025 |
| May 9, 2025 | CHE CHEMED CORP | MOption exercise Capital Stock | +9,956 | $462.04 | $4.6M | 33,012 | May 12, 2025 |
| May 9, 2025 | CHE CHEMED CORP | FTax withholding Capital Stock | -23,000 | $569.70 | $13M | 10,012 | May 12, 2025 |
| May 9, 2025 | CHE CHEMED CORP | MOption exercise Stock Option (right to buy with tandem tax withholding)derivative | -16,132 | $445.35 | $7.2M | 46,128 | May 12, 2025 |
| May 9, 2025 | CHE CHEMED CORP | MOption exercise Stock Option (right to buy with tandem tax withholding)derivative | -9,956 | $462.04 | $4.6M | 36,172 | May 12, 2025 |
| Feb 14, 2025 | CHE CHEMED CORP | MOption exercise Capital Stock | +1,131 | $553.39 | $626k | 7,240 | Feb 18, 2025 |
| Feb 14, 2025 | CHE CHEMED CORP | MOption exercise Capital Stock | +342 | $553.39 | $189k | 7,582 | Feb 18, 2025 |
| Feb 14, 2025 | CHE CHEMED CORP | FTax withholding Capital Stock | -658 | $553.39 | $364k | 6,924 | Feb 18, 2025 |
| Feb 14, 2025 | CHE CHEMED CORP | MOption exercise Performance Stock Unitsderivative | -560 | $0.00 | $0 | 2,680 | Feb 18, 2025 |
| Feb 14, 2025 | CHE CHEMED CORP | MOption exercise Performance Stock Unitsderivative | -560 | $0.00 | $0 | 2,120 | Feb 18, 2025 |
| Feb 14, 2025 | CHE CHEMED CORP | AGrant or award Performance Stock Unitsderivative | +1,264 | $0.00 | $0 | 3,384 | Feb 18, 2025 |
| Oct 22, 2024 | CHE CHEMED CORP | AGrant or award Stock Option (right to buy with tandem tax withholding)derivative | +16,788 | $597.70 | $10M | 62,260 | Oct 23, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.